YU81601A - Nova so 5-/4-/2-(n-metil-n-(2-piridil)amino)etoksi/ tiazolidin-2,4-dion hidrohlorid monohidrat - Google Patents

Nova so 5-/4-/2-(n-metil-n-(2-piridil)amino)etoksi/ tiazolidin-2,4-dion hidrohlorid monohidrat

Info

Publication number
YU81601A
YU81601A YU81601A YUP81601A YU81601A YU 81601 A YU81601 A YU 81601A YU 81601 A YU81601 A YU 81601A YU P81601 A YUP81601 A YU P81601A YU 81601 A YU81601 A YU 81601A
Authority
YU
Yugoslavia
Prior art keywords
ethoxy
amino
methyl
hydrochloride monohydrate
tiazolydine
Prior art date
Application number
YU81601A
Other languages
English (en)
Inventor
Paul David James Blacker
Andrew Simon Craig
Robert Gordon Giles
Michael John Sasse
Original Assignee
Smithkline Beecham P.L.C.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham P.L.C. filed Critical Smithkline Beecham P.L.C.
Publication of YU81601A publication Critical patent/YU81601A/sh
Publication of RS50137B publication Critical patent/RS50137B/sr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

5-(4-(2-(N-metil-N-(2-piridil)amino)etoksi)benzil)tiazolidin-2,4-dion, hidrohlorid monohidrat karakterisan time što: (i) obezbedjuje infracrveni spektar koji sadrži vrhove na 3392, 2739, 1751, 1325 i 713 cm-1; i/ili (ii) obezbedjuje uzorak difrakcije praha X-zraka (XRPD) koji sadrži vrhove na 9.1, 12,0, 15.7, 16.3 i 18.9В°2θ; postupak za dobijanje takvog jedinjenja, farmaceutski preparat koji sadrži takvo jedinjenje i korišćenje takvog jedinjenja u medicini.
YUP-816/01A 1999-04-20 2000-04-19 Nova so 5-/4-/2-(n-metil-n-(2-piridil) amino)etoksi/benzil/ tiazolidin-2,4-dion hidrohlorid monohidrat RS50137B (sr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9909075.5A GB9909075D0 (en) 1999-04-20 1999-04-20 Novel pharmaceutical

Publications (2)

Publication Number Publication Date
YU81601A true YU81601A (sh) 2004-09-03
RS50137B RS50137B (sr) 2009-03-25

Family

ID=10851922

Country Status (42)

Country Link
EP (2) EP1173437B1 (sh)
JP (2) JP4283450B2 (sh)
KR (1) KR100677815B1 (sh)
CN (2) CN101125851A (sh)
AP (1) AP1680A (sh)
AR (2) AR023567A1 (sh)
AT (1) ATE262524T1 (sh)
AU (1) AU773112B2 (sh)
BG (1) BG65428B1 (sh)
BR (1) BR0009898A (sh)
CA (1) CA2370270A1 (sh)
CO (1) CO5170420A1 (sh)
CZ (1) CZ300934B6 (sh)
DE (1) DE60009276T2 (sh)
DK (1) DK1173437T3 (sh)
DZ (1) DZ3163A1 (sh)
EA (1) EA004769B1 (sh)
EG (1) EG23946A (sh)
ES (1) ES2214267T3 (sh)
GB (1) GB9909075D0 (sh)
HK (1) HK1045304B (sh)
HR (1) HRP20010771B1 (sh)
HU (1) HUP0200785A3 (sh)
IL (1) IL146077A0 (sh)
MA (1) MA26784A1 (sh)
MX (1) MXPA01010695A (sh)
MY (1) MY125209A (sh)
NO (1) NO320573B1 (sh)
NZ (1) NZ515164A (sh)
OA (1) OA11867A (sh)
PE (1) PE20010047A1 (sh)
PL (1) PL351115A1 (sh)
PT (1) PT1173437E (sh)
RS (1) RS50137B (sh)
SI (1) SI1173437T1 (sh)
SK (1) SK284990B6 (sh)
TR (1) TR200103041T2 (sh)
TW (1) TWI291463B (sh)
UA (1) UA72245C2 (sh)
UY (1) UY26113A1 (sh)
WO (1) WO2000063206A2 (sh)
ZA (1) ZA200108721B (sh)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9909075D0 (en) * 1999-04-20 1999-06-16 Smithkline Beecham Plc Novel pharmaceutical
GB0006133D0 (en) 2000-03-14 2000-05-03 Smithkline Beecham Plc Novel pharmaceutical
GB0014005D0 (en) * 2000-06-08 2000-08-02 Smithkline Beecham Plc Novel pharmaceutical
JP2005513038A (ja) * 2001-11-21 2005-05-12 スミスクライン　ビーチャム　パブリック　リミテッド　カンパニー ５−［４−［２−（ｎ−メチル−ｎ−（２−ピリジル）アミノ）エトキシ］ベンジル］チアゾリジン−２，４−ジオンベンゼンスルホン酸塩；その製造方法；多形体ｉ、ｉｉおよびｉｉｉ；および医薬上活性な成分としてのその使用
KR100450700B1 (ko) * 2002-03-22 2004-10-01 주식회사종근당 티아졸리딘디온 유도체 화합물 및 이를 함유하는 약제학적조성물
CZ298424B6 (cs) * 2005-05-24 2007-09-26 Zentiva, A. S. Zpusob krystalizace rosiglitazonu a jeho derivátuze smesných rozpouštedel
EP1842850A1 (en) * 2006-03-23 2007-10-10 Sandoz AG Rosiglitazone hydrochloride hemihydrate

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0842925A1 (en) * 1987-09-04 1998-05-20 Beecham Group Plc Substituted thiazolidinedione derivatives
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
GB9909075D0 (en) * 1999-04-20 1999-06-16 Smithkline Beecham Plc Novel pharmaceutical

Also Published As

Publication number Publication date
AU773112B2 (en) 2004-05-20
HUP0200785A2 (en) 2002-08-28
JP4283450B2 (ja) 2009-06-24
EA004769B1 (ru) 2004-08-26
AR023567A1 (es) 2002-09-04
DE60009276D1 (de) 2004-04-29
HUP0200785A3 (en) 2004-03-29
KR100677815B1 (ko) 2007-02-05
HK1045304B (zh) 2004-12-24
HK1045304A1 (en) 2002-11-22
UY26113A1 (es) 2000-12-29
IL146077A0 (en) 2002-07-25
PT1173437E (pt) 2004-06-30
JP2009161544A (ja) 2009-07-23
WO2000063206A3 (en) 2001-02-22
BG106120A (en) 2002-05-31
TR200103041T2 (tr) 2002-03-21
NO320573B1 (no) 2005-12-27
GB9909075D0 (en) 1999-06-16
EP1173437B1 (en) 2004-03-24
EP1411054A1 (en) 2004-04-21
ATE262524T1 (de) 2004-04-15
OA11867A (en) 2006-03-02
SI1173437T1 (en) 2004-06-30
TWI291463B (en) 2007-12-21
NO20015105L (no) 2001-12-19
DE60009276T2 (de) 2004-08-26
DK1173437T3 (da) 2004-07-12
DZ3163A1 (fr) 2000-10-26
CZ20013758A3 (cs) 2003-05-14
EA200101102A1 (ru) 2002-04-25
CA2370270A1 (en) 2000-10-26
MY125209A (en) 2006-07-31
ES2214267T3 (es) 2004-09-16
JP2002542243A (ja) 2002-12-10
PE20010047A1 (es) 2001-03-10
CN1327446A (zh) 2001-12-19
CO5170420A1 (es) 2002-06-27
HRP20010771B1 (en) 2005-06-30
NZ515164A (en) 2004-02-27
CZ300934B6 (cs) 2009-09-16
NO20015105D0 (no) 2001-10-19
SK284990B6 (sk) 2006-04-06
HRP20010771A2 (en) 2002-12-31
AP2001002332A0 (en) 2001-12-31
SK14892001A3 (sk) 2002-02-05
CN101125851A (zh) 2008-02-20
RS50137B (sr) 2009-03-25
ZA200108721B (en) 2002-09-13
BG65428B1 (bg) 2008-07-31
UA72245C2 (uk) 2005-02-15
MXPA01010695A (es) 2002-06-04
BR0009898A (pt) 2002-04-16
PL351115A1 (en) 2003-03-24
MA26784A1 (fr) 2004-12-20
EG23946A (en) 2008-01-22
EP1173437A2 (en) 2002-01-23
AR023563A1 (es) 2002-09-04
WO2000063206A2 (en) 2000-10-26
AU4131100A (en) 2000-11-02
AP1680A (en) 2006-11-27
KR20010112446A (ko) 2001-12-20

Similar Documents

Publication Publication Date Title
AP1545A (en) Hydrochloride salts of 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione.
YU75201A (sh) Novi polimorfni oblik 5-/4-/2-(n-metil-n-(2-piridil)amino/ etoksi/benzil/tiazolidin-2,4-dion, soli maleinske kiseline
BG104606A (en) Substituted thiazolidinedione derivative, process for its preparation and its pharmaceutical use
YU36200A (sh) Hidrat od 5-(4-2-n-metil-n-(2-piridil)amino)etoksi)benzil) tiazolidin-2,4-diona soli maleinske kiseline
YU81601A (sh) Nova so 5-/4-/2-(n-metil-n-(2-piridil)amino)etoksi/ tiazolidin-2,4-dion hidrohlorid monohidrat
YU75401A (sh) Polimorfni oblik soli maleinske kiseline 5-/4-/2-(n-metil- -(2-piridil)amino)etoksi/-benzil/tiazolidin-2,4-dion
YU81501A (sh) Novi farmaceutikal
HUP0402038A2 (hu) 2-Amino-4-heteroaril-etil-tiazolin-származékok alkalmazása az indukálható NO-szintetáz inhibitoraként, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
AP1814A (en) Tartrate salts of thiazolidinedione derivative.
AP1715A (en) The hydrochloride salt of 5-[ 4 -[2 -(n-methyl-n- (2-pyridyl) amino) ethoxy]benzyl]thiazolidine -2,4-dione
PT1349855E (pt) Sal misilato de 5-{4-[2-(n-metil-n-(2-piridil)amino)etoxi]benzil}tiazolidino-2, 4-diona
AP1785A (en) Tartrate salt of thiazolidinedione derivative.
ATE329914T1 (de) Rosiglitazon-edisylate und ihre verwendung als antidiabetika
DE60115062D1 (de) Ein thiazolidindionderivat und seine verwendung als antidiabetikum
AP2002002673A0 (en) Thiazolidinedione salt for the treatment of diabetes mellitus.
ATE343574T1 (de) Ein thiazolidindionderivat und seine verwendung als antidiabetikum
CY1107767T1 (el) Παραγωγο θειαζολιδινοδιονης και χρηση αυτου σαν αντιδιαβητικο
AP2002002684A0 (en) 5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2-pyridyl) amino) ethoxy)benzyl) thiazolidine-2,4-dione hydriodide as pharmaceutical
TH54864B (th) อนุพันธ์ไธอะโซลิดีนไดโอน และการใช้สารนี้เป็นยารักษาโรคเบาหวาน
SI1448559T1 (sl) 5-(4-(2-(n-metil-n-(2-piridil)amino)etoksi)benzil-tiazolidin-2,4-dion- benzensulfonat; postopek za njegovo pripravo; njegovi polimorfi i, ii, iii; in njegova uporaba kot farmacevtska uäśinkovina
ECSP003434A (es) Nuevos compuestos